Latest Feature

Big data and personalized medicine: Q&A with Definiens CEO Thomas Heydler

Definiens CEO Thomas Heydler discusses his ambition to position his company at the forefront of the coming revolution in personalized and predictive medicines.

The making of an icon | Dr. Tom Fogarty's obsession with innovation

Medtech icon Dr. Tom Fogarty tells MassDevice.com about his unconventional path from upstart tinkerer in the suburbs of Cincinnati to healthcare celebrity in the heart of Silicon Valley, in Part 1 of a 3-part series.

DNA analysis in your pocket - Q&A with QuantuMDx founder Jonathan O'Halloran

QuantuMDx envisions a future where laboratory-quality diagnostics are mobile, cheap and available to everyone, from healthcare providers in developing countries to parents dealing with ill children.

Medical device tax: At least $510B paid in 2013

A MassDevice.com analysis of reported payments for the medical device tax last year finds that 14 companies accounted for more than 97% of the nearly $500 million collected.

Breathing easier with SinuSys | MassDevice Q&A

SinuSys CEO Thomas Schreck and CMO Dr. Jerome Hester tell MassDevice.com how they hope to replace sinus surgery with a simple, in-office procedure and how a doctor and his patient formed a company together.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Cardiac Dimensions closes $20M equity round

April 17, 2014 by Brad Perriello

Cardiac Dimensions raises $20 million from a syndicate of international investors for its Carillon mitral valve implant.

Cardiac Dimensions closes $20M equity round

Cardiac Dimensions said it raised $20 million from a syndicate of international investors for its Carillon mitral valve implant.

M.H. Carnegie & Co. and Lumira Capital led the round for Kirkland, Wash.-based Cardiac Dimensions, according to a press release. Investors in Australia, the U.S. and Canada also participated, the company said.

Philips takes down Ohio manufacturing following inspection

April 17, 2014 by Arezu Sarvestani

Philips voluntarily suspends manufacturing at an Ohio facility after an FDA investigation turns up "certain issues in the general area of manufacturing process controls."

Philips takes down Ohio PET/CT manufacturing following inspection

Philips Healthcare (NYSE:PHG) halted work at an Ohio manufacturing facility after an FDA inspection turned up some concerns with process controls, a company spokesman confirmed with MassDevice.com today.

Mainstay Medical readies European IPO

April 17, 2014 by Brad Perriello

Mainstay Medical looks to raise up to $42 million with an initial public offering on the EuroNext stock exchange.

Mainstay Medical readies European IPO

Mainstay Medical is preparing an initial public offering on the EuroNext stock exchange that could be worth up to $42 million, according to a regulatory filing.

Mainstay, which last month launched a new clinical trial of its ReActiv8 implantable neurostimulator for chronic lower back pain, said it plans to offer some 1.1 million shares at €20-€27 per share, or about $27.77 to $37.50 per share.

Baxter blows away Wall Street as renal sales surge in Q1

April 17, 2014 by Arezu Sarvestani

Baxter International's medical products division gets a major boost in the company's 1st quarter, pushing adjusted per-share earnings 9¢ above expectations.

Baxter blows away Wall Street with dialysis sales surge in Q1

Illinois healthcare titan Baxter (NYSE:BAX) isn't getting much Wall Street love today after posting Q1 adjusted per-share earnings that blew away expectations.

FDA warns Endo Health on AMS pelvic mesh plant

April 17, 2014 by Brad Perriello

The FDA sends a warning letter to Endo Health's American Medical Systems subsidiary over procedural violations at the Minnetonka, Minn., plant that makes pelvic mesh products.

FDA warns Endo Health on pelvic mesh plant

Endo Health Solutions (NSDQ:ENDP) said the FDA warned it about procedural violations at a Minnesota plant run by its American Medical Systems subsidiary that makes pelvic mesh products.

mHealth: Google Glass poses great potential for hospitals, docs say

April 17, 2014 by Aubrie Johnson

Hospitals are using Google's reality-augmenting Glass technology to help sick kids and better treat patients, but some warn that the tech get could get in the way of patient engagement.

mHealth: Google Glass poses great potential for hospitals, docs say

Dr. Steve Horng, an emergency medicine physician at BIDMC, uses Google Glass to scan a QR code outside a patient room in the Emergency Department.

GE Healthcare's Q1 sales, profits slide

April 17, 2014 by Brad Perriello

Sales and profits were down during the 1st quarter for GE Healthcare, which cited "market volatility" for the declines.

keys: ge healthcare, general electric, earnings

GE Healthcare's Q1 sales, profits slide

GE Healthcare (NYSE:GE) saw its sales and profits decline by single digits during the 1st quarter due to "market volatility.

Ex-Stryker exec dodges jail in insider trading scheme

April 17, 2014 by Brad Perriello

Former Stryker executive Mark Foldy, who pleaded guilty last year for his part in an insider trading scheme, dodges a jail sentence.

Ex-Stryker exec dodges jail in insider trading scheme

A former Stryker (NYSE:SYK) marketing executive escaped a jail sentence yesterday, instead drawing 6 months of home confinement and 2 years of probation for passing along inside information ahead of Stryker's 2011 acquisition of Orthovita.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp